ITeos Therapeutics (NASDAQ:ITOS) reported quarterly earnings of $1.86 per share. This is a 487.5 percent increase over losses of $(0.48) per share from the same period last year.
Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $73
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $67 to $73.